180 related articles for article (PubMed ID: 36094106)
1. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
Smith RH; Bloomer H; Fink D; Keyvanfar K; Nasimuzzaman M; Sancheznieto F; Dutta R; Guenther Bui K; Alvarado LJ; Bauer TR; Hickstein DD; Russell DW; Malik P; van der Loo JCM; Highfill SL; Kuhns DB; Pirooznia M; Larochelle A
Hum Gene Ther; 2022 Dec; 33(23-24):1293-1304. PubMed ID: 36094106
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
3. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1.
Bauer TR; Schwartz BR; Liles WC; Ochs HD; Hickstein DD
Blood; 1998 Mar; 91(5):1520-6. PubMed ID: 9473215
[TBL] [Abstract][Full Text] [Related]
4. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Bauer TR; Olson EM; Huo Y; Tuschong LM; Allen JM; Li Y; Burkholder TH; Russell DW
Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
Leon-Rico D; Aldea M; Sanchez-Baltasar R; Mesa-Nuñez C; Record J; Burns SO; Santilli G; Thrasher AJ; Bueren JA; Almarza E
Hum Gene Ther; 2016 Sep; 27(9):668-78. PubMed ID: 27056660
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
Hunter MJ; Tuschong LM; Fowler CJ; Bauer TR; Burkholder TH; Hickstein DD
Mol Ther; 2011 Jan; 19(1):113-21. PubMed ID: 20859258
[TBL] [Abstract][Full Text] [Related]
8. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy.
Bauer TR; Hai M; Tuschong LM; Burkholder TH; Gu YC; Sokolic RA; Ferguson C; Dunbar CE; Hickstein DD
Blood; 2006 Nov; 108(10):3313-20. PubMed ID: 16868255
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
Gopinath C; Chodisetty S; Ghosh A; Nelson EJR
Gene; 2019 Aug; 710():265-272. PubMed ID: 31200085
[TBL] [Abstract][Full Text] [Related]
10. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope.
Bauer TR; Miller AD; Hickstein DD
Blood; 1995 Sep; 86(6):2379-87. PubMed ID: 7662985
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Nelson EJ; Tuschong LM; Hunter MJ; Bauer TR; Burkholder TH; Hickstein DD
Gene Ther; 2010 May; 17(5):672-7. PubMed ID: 20164857
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
Hunter MJ; Zhao H; Tuschong LM; Bauer TR; Burkholder TH; Persons DA; Hickstein DD
Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
14. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
15. In-Vivo Gene Therapy with Foamy Virus Vectors.
Rajawat YS; Humbert O; Kiem HP
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for leukocyte adhesion deficiency.
Bauer TR; Hickstein DD
Curr Opin Mol Ther; 2000 Aug; 2(4):383-8. PubMed ID: 11249768
[TBL] [Abstract][Full Text] [Related]
17. Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector.
Zucali JR; Ciccarone T; Kelley V; Park J; Johnson CM; Mergia A
Virology; 2002 Oct; 302(2):229-35. PubMed ID: 12441067
[TBL] [Abstract][Full Text] [Related]
18. Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I.
Mesa-Núñez C; Damián C; Fernández-García M; Díez B; Rao G; Schwartz JD; Law KM; Sevilla J; Río P; Yáñez R; Bueren JA; Almarza E
Mol Ther Methods Clin Dev; 2022 Sep; 26():459-470. PubMed ID: 36092365
[TBL] [Abstract][Full Text] [Related]
19. Feline leukocyte adhesion (CD18) deficiency caused by a deletion in the integrin β
Bauer TR; Pratt SM; Palena CM; Raj K; Giger U
Vet Clin Pathol; 2017 Sep; 46(3):391-400. PubMed ID: 28750142
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors.
Vassilopoulos G; Trobridge G; Josephson NC; Russell DW
Blood; 2001 Aug; 98(3):604-9. PubMed ID: 11468157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
